In approximately 40% to 50% of cases, standard evaluations reveal no single identifiable cause (unexplained RPL). Reassuringly, evidence shows that supportive care yields favorable live-birth outcomes even when tests are normal.
Testing is never one-size-fits-all; our specialists tailor investigations to your specific medical history:
| Identified Cause | Clinical Evaluation & Treatment Approach |
| Uterine Septum / Adhesions | Minimally invasive hysteroscopic corrective surgery |
| Antiphospholipid Syndrome (APS) | Low-dose aspirin and prophylactic low-molecular-weight heparin (LMWH) |
| Thyroid / Endocrine Disorder | Targeted medical management (e.g., levothyroxine) to optimize hormonal levels |
| Luteal Phase / Bleeding Risks | Micronized vaginal progesterone support in early pregnancy where clinically indicated |
| Genetic Translocations / Advanced Age | In Vitro Fertilization (IVF) with PGT-A (preimplantation genetic testing) |
Note: While IVF and PGT-A can screen embryos for major numerical chromosome abnormalities before transfer, they cannot prevent all types of pregnancy loss.
Years Experience
IVF Treatment Success Rate
Happy Couples
Lower Cost
Seeking specialized recurrent pregnancy loss treatment in Delhi allows couples access to advanced reproductive diagnostics, experienced embryology laboratories, and continuous pregnancy monitoring.
At Little Angel IVF, Dr Mona Dahiya works directly with couples through structured consultations, targeted RPL testing IVF protocols, and close clinical monitoring during the critical first trimester.
Recurrent miscarriage is the loss of two or more consecutive clinical pregnancies before 20–24 weeks of gestation, warranting medical evaluation.
Primary causes include random chromosomal abnormalities in the embryo, uterine structural defects, blood-clotting disorders like APS, untreated thyroid or metabolic imbalances, and parental genetic variations.
Testing typically includes pelvic imaging (such as 3D ultrasound), screening for antiphospholipid syndrome, hormonal and metabolic blood tests, and genetic karyotyping when indicated.
Yes. When a specific cause—such as a uterine septum, APS, or thyroid condition—is identified, targeted medical or surgical treatments significantly improve pregnancy continuation rates.
IVF is not required for every patient. However, IVF paired with preimplantation genetic testing (PGT-A) may be recommended if parental genetic translocations are identified or for couples with repeated chromosomal losses.
